6 out of 10 Doctors Have Already Prescribed Biosimilar Medicines, According to EuropaBio Paper

20 April 2016

Medicines for Europe and its Biosimilar Medicines Group took note […]

Medicines for Europe Reinforces its Commitment to Promote Universal Access to Health

19 April 2016

Over 100 participants will explore different ways and opportunities to […]

100% increase in Patient Access to Biologic Treatments thanks to Biosimilar Medicines

30 March 2016

Biosimilar medicines represent an essential opportunity to optimise patient access to […]

EGA becomes Medicines for Europe

10 March 2016

The European Generic and Biosimilar Medicines Association is now Medicines […]

IGBA calls for full transparency and new timelines for impact assessment with regard to the voluntary WHO biological qualifier (BQ) proposal

2 March 2016

The European Biosimilars Group Appoints New Leadership Team With Sandoz’ Carol Lynch and Polpharma’s Klaus Martin

10 February 2016

Last week in Brussels, the European Biosimilar medicines Group (EBG […]

EGA Welcomes the Delegated Regulation as a Tool To Fight Counterfait Medicines

9 February 2016

Brussels – The European Generic and Biosimilar Medicines Association (EGA) welcomes […]

Shaping The 2020 Regulatory Landscape For Patient Needs

28 January 2016

London – 61 regulators from 25 countries made progress in improving the […]

Industry Coming Together To Improve Safety For Patients

26 January 2016

London – In London this week, the European Generic and Biosimilar medicines […]

Global Pharmaceutical Industry Calls on Governments to Work with Them to Beat the Rising Threat of Drug Resistance

21 January 2016

More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology […]